Opinion: The Many Costs of Trump’s Attack on Science
Read full article in The New York Times
To the Editor:
The data cited throughout this article confirm what those of us in the research community have been witnessing for more than a year and a half: America’s global leadership in science, technology and medical progress is increasingly at stake. From disruptions to clinical studies to federal funding cuts to overreach by the Office of Management and Budget, our nation’s health, prosperity and security are on the chopping block.
That’s not what Americans want. Or deserve.
Our public opinion survey reveals that nearly 7 out of 10 Americans say Congress should invest more taxpayer dollars to advance science and technology. More specifically, an even larger majority of Americans from across the political spectrum — 9 in 10 — say it is important for the United States to be a global leader in research that improves health.
By pausing, canceling or defunding research, or by putting political bureaucrats in charge of grants, we also risk America’s competitiveness.
A recent article in The Journal of Biochemistry outlines Japan’s Seventh Basic Plan, a five-year road map to expand funding, revitalize the country’s research ecosystem and increase its global leadership in science and technology. Those are the kinds of investments our own government should be making in science, technology and medical research, not dismantling it.
I urge lawmakers to listen to the American public, especially as the current continuing resolution funding our government expires on Dec. 11. We have an opportunity to invest in research and fully support scientists’ lifesaving work. Our health and that of future generations depend on it.
Russ Paulsen
Arlington, Va.
The writer is the president and chief executive of Research!America.